What is BPC-157?

BPC-157 is a laboratory-synthesised oligopeptide of fifteen amino acids — a "pentadecapeptide" — representing a specific sequence originally identified within a larger protein found in gastric tissue. In research it is handled as an isolated, well-characterised peptide with consistent physicochemical properties, which makes it a popular tool across biochemical, cellular and preclinical studies.

Research use only. BPC-157 is supplied strictly for in-vitro laboratory research. This page does not describe dosing, administration, or use in humans or animals, and makes no therapeutic claims.

What researchers study

In biochemical and cell-based work, BPC-157 has been observed to interact with several signalling pathways, including those associated with nitric-oxide-related processes, growth-factor signalling, and regulators of cytoskeletal dynamics. The molecular and cellular effects reported across studies vary substantially with the experimental model, peptide concentration, exposure time and methodology — so BPC-157 is used primarily as a probe for short-peptide signalling mechanisms rather than to draw conclusions about defined biological outcomes.

Typical research applications include:

• Analysing short-peptide signalling mechanisms in vitro
• Exploring nitric-oxide-associated and growth-factor-related pathways
• Investigating cytoskeletal organisation and cell–matrix interaction behaviour
• Mechanistic study in preclinical or ex-vivo models

How it is supplied

BPC-157 is supplied as a lyophilised vial with a batch-specific Certificate of Analysis (HPLC + mass spectrometry), and must be kept refrigerated at 2–8°C for stability. It also appears as a component in several research compound sets, including the Glow Stack, Wolverine Stack and Klow Stack, where it is studied alongside other peptides.

Related reading

• New to the topic? Start with what are research peptides?
• Compare combined formulations in what is the Glow Stack?